October 2020 Vol. 12 Issue 101

Abstracts & Commentary

Ketogenic Diet and Breast Cancer

by Tina Kaczor, ND, FABNO  Adoption of a ketogenic diet may help women with breast cancer reduce fat mass, a risk factor for recurrence.

Role of Insulin-Like Growth Factor 1 in HER2-Positive Breast Cancer Patients

by Jacob Schor, ND, FABNO  This large study looks at the relationship between IGF-1 levels, body mass index, and recurrence and mortality in HER2+ breast cancer patients, with surprising results.

Chemical Hair Treatments May Pose Highest Cancer Risk to Black Women

by Maxwell Crispo, ND  Use of permanent hair dye was associated with a 45% increase in breast cancer risk in Black women compared to a 7% increase in White women. In contrast, hair straightener use was associated with an 18% increased risk for all participants.

Mindfulness-Based Interventions: Do They Decrease Anxiety in Cancer Patients?

by Poorvi Shah, DO  A meta-analysis of 28 studies, involving about 3,000 participants, finds that mindfulness-based interventions can reduce anxiety for up to 6 months after the intervention but not longer.

Podcasts

How is the Covid-19 Pandemic Impacting Cancer Care?

by Natural Medicine Journal Among the tragedies of the Covid-19 pandemic is how it is affecting people at risk of cancer and those being treated for cancer. In this episode, Natural Medicine Journal Publisher Karolyn Gazella and Editor-in-Chief Tina Kaczor, ND, FABNO, discuss how the pandemic has negatively impacted cancer care and what integrative healthcare practitioners can do to help.

An Innovative Approach to Integrative Oncology: A Conversation with Integrative Oncologist Isaac Eliaz, MD, LAc

by Natural Medicine Journal On this episode, integrative clinician and researcher Isaac Eliaz, MD, shares some of the more progressive methods he uses with people who have cancer.

Peer-Reviewed Articles

Antiangiogenic Phytochemicals Best Poised for Clinical Trial Testing

by Athanasios Psihogios, ND  Green tea, curcumin, resveratrol, and ginsenosides have some of the most robust evidence for inhibiting malignant angiogenesis in a clinically meaningful way.